Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease-Reference-Cited by-同舟云学术

Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease

Published:2023-05 Issue: Volume:91 Page:104569
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Bjune Mona Synnøve^ORCID,Lawrence-Archer Laurence,Laupsa-Borge Johnny,Sommersten Cathrine Horn^ORCID,McCann Adrian,Glastad Robert Clay,Johnston Iain George,Kern Matthias,Blüher Matthias,Mellgren Gunnar^ORCID,Dankel Simon N.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference63 articles.

1. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

2. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes;Perry;Nature,2014

3. Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS;Miyazaki;Springerplus,2015

4. Aqueous metabolite trends for the progression of nonalcoholic fatty liver disease in female bariatric surgery patients by targeted 1H-NMR metabolomics;Robinson;Metabolites,2021

5. Distinguishing NASH histological severity using a multiplatform metabolomics approach;Ioannou;Metabolites,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cav3.2 deletion attenuates nonalcoholic fatty liver disease in mice;Gene;2024-12

2. Mitochondrial dysfunction and onset of type 2 diabetes along with its complications: a multi-omics Mendelian randomization and colocalization study;Frontiers in Endocrinology;2024-08-30

3. Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer;Cell Death & Disease;2024-07-18

4. SWATH-MS reveals that bisphenol A and its analogs regulate pathways leading to disruption in insulin signaling and fatty acid metabolism;Food and Chemical Toxicology;2024-06

5. Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective;Metabolites;2024-04-12